ProfileGDS4718 / 226025_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 93% 93% 95% 92% 92% 94% 95% 95% 95% 93% 95% 93% 91% 93% 95% 92% 91% 80% 94% 94% 95% 95% 94% 95% 95% 91% 95% 92% 93% 90% 94% 95% 89% 93% 93% 94% 94% 94% 95% 94% 89% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.225595
GSM549102patient 115, normal, homogenized [OPG study]9.9668794
GSM549104patient 119, normal, homogenized [OPG study]9.8293893
GSM549108patient 138, normal, homogenized [OPG study]9.7840993
GSM549119patient 077, normal, homogenized [OPG study]10.215995
GSM549133patient 032, cancer, homogenized [OPG study]9.6559592
GSM549139patient 042, cancer, homogenized [OPG study]9.5805592
GSM549099patient 107, normal, homogenized [OPG study]9.9489894
GSM549109patient 139, normal, homogenized [OPG study]10.265995
GSM549110patient 046, normal, homogenized [OPG study]10.273195
GSM549114patient 063, normal, homogenized [OPG study]10.435895
GSM549122patient 082, normal, homogenized [OPG study]9.7180793
GSM549134patient 033, cancer, homogenized [OPG study]10.344395
GSM549136patient 036, cancer, homogenized [OPG study]9.8617893
GSM549140patient 044, cancer, homogenized [OPG study]9.4485891
GSM549111patient 047, normal, homogenized [OPG study]9.9822893
GSM549113patient 057, normal, homogenized [OPG study]10.37795
GSM549132patient 031, cancer, homogenized [OPG study]9.5154492
GSM549137patient 038, cancer, homogenized [OPG study]9.2785991
GSM549142patient 047, cancer, homogenized [OPG study]7.6062280
GSM549100patient 110, normal, homogenized [OPG study]9.9170294
GSM549107patient 135, normal, homogenized [OPG study]10.144694
GSM549115patient 068, normal, homogenized [OPG study]10.499895
GSM549116patient 072, normal, homogenized [OPG study]10.398295
GSM549120patient 078, normal, homogenized [OPG study]9.9843994
GSM549131patient 030, cancer, homogenized [OPG study]10.1895
GSM549118patient 074, normal, homogenized [OPG study]10.340195
GSM549129patient 027, cancer, homogenized [OPG study]9.3137191
GSM549123patient 088, normal, homogenized [OPG study]10.243595
GSM549124patient 006, cancer, homogenized [OPG study]9.3903192
GSM549126patient 015, cancer, homogenized [OPG study]9.5903693
GSM549128patient 025, cancer, homogenized [OPG study]9.2618790
GSM549103patient 117, normal, homogenized [OPG study]9.9385594
GSM549117patient 073, normal, homogenized [OPG study]10.357895
GSM549138patient 041, cancer, homogenized [OPG study]9.0996189
GSM549141patient 045, cancer, homogenized [OPG study]9.7672993
GSM549130patient 028, cancer, homogenized [OPG study]9.6747593
GSM549101patient 111, normal, homogenized [OPG study]9.9566294
GSM549105patient 128, normal, homogenized [OPG study]9.9023594
GSM549106patient 134, normal, homogenized [OPG study]10.234194
GSM549112patient 048, normal, homogenized [OPG study]10.397695
GSM549125patient 011, cancer, homogenized [OPG study]10.000994
GSM549127patient 024, cancer, homogenized [OPG study]9.0073189
GSM549135patient 035, cancer, homogenized [OPG study]9.6794592